Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03444116 · ClinicalTrials.gov registry record
Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy
A clinical trial, sponsored by Gillette Children's Specialty Healthcare.
- Completed
- Registry status
- 62
- Enrollment target
NCT03444116: Completed study, sponsored by Gillette Children's Specialty Healthcare.
NCT03444116 is a clinical trial that has completed, run by Gillette Children's Specialty Healthcare. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03444116 has completed, sponsored by Gillette Children's Specialty Healthcare.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
Excessive anteversion is commonly observed in the cerebral palsy (CP) population. This can be treated by an orthopedic surgery, called femoral derotation osteotomy (FDO), to de-rotate the femur. It is a vital aspect of patient care to understand if the effects of an FDO are maintained long-term. The results of this study will have direct clinical impact by equipping providers with the necessary information to counsel families by providing families the information needed to make the most informed decision possible about this aspect of their child's healthcare.
Primary Outcome
Compare gait kinematics and kinetics across groups
Interventions
- BEHAVIORAL Surveys
- DIAGNOSTIC_TEST Motion Analysis
- DIAGNOSTIC_TEST sterEOS Imaging of Lower Extremities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2019-11-15 |
What the finished NCT03444116 record still lists
NCT03444116 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Surveys is the first listed.
NCT03444116 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03444116 about?
NCT03444116 is a clinical study titled "Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy". Excessive anteversion is commonly observed in the cerebral palsy (CP) population. This can be treated by an orthopedic surgery, called femoral derotation osteotomy (FDO), to de-rotate the femur. It is a vital aspect of patient care to understand if the effects of an FDO are maintained long-term. The...
What is the current status of trial NCT03444116?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2017-09-12. Estimated completion is 2019-11-15.
What interventions are being tested in trial NCT03444116?
The interventions under investigation include: Surveys (BEHAVIORAL), Motion Analysis (DIAGNOSTIC_TEST), sterEOS Imaging of Lower Extremities (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03444116?
This trial is sponsored by Gillette Children's Specialty Healthcare, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI